WebAbout SI-BONE, Inc. SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since 2009, when SI-BONE introduced the iFuse Implant System for minimally invasive surgery of the SI joint, over 3,000 surgeons have performed a combined total of more than 80,000 SI joint ...
SI-BONE To Report First Quarter 2024 Financial Results on May 1, …
WebApr 10, 2024 · About SI-BONE, Inc. SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since 2009, when SI-BONE introduced the iFuse Implant System for minimally invasive surgery of the SI joint, over 3,000 surgeons have performed a combined total of more than 80,000 SI joint ... WebApr 14, 2024 · SI-BONE Price Performance. SIBN opened at $20.03 on Friday. The firm has a 50-day moving average price of $18.89 and a 200-day moving average price of $16.34. … bj\u0027s wholesale corporate address
SI-BONE, Inc. (SIBN) Company Profile & Overview - Stock Analysis
WebApr 14, 2024 · Ensign Peak Advisors Inc acquired a new position in SI-BONE during the third quarter worth approximately $48,000. Tower Research Capital LLC TRC raised its holdings in shares of SI-BONE by 151.1% ... WebJun 1, 2024 · Item 1.01 Entry into a Material Definitive Agreement. Loan Agreement On May 29, 2024, SI-BONE, Inc. entered into a Loan and Security Agreement with Solar Capital Ltd., a Maryland corporation , as... April 10, 2024 WebJan 9, 2024 · SI-BONE, Inc. announced that on January 6, 2024, the company refinanced the existing $35 million SVB Term Loan with a new $51 million Credit Facility with Silicon Valley Bank (SVB) including a new $36 million Term Loan and … datin toh siew chuon